ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 21 filers reported holding ACHILLES THERAPEUTICS PLC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $556,428 | +44166.3% | 682,734 | -32.1% | 0.00% | -50.0% |
| Q1 2024 | $1,257 | +183.1% | 1,005,759 | +101.6% | 0.00% | +100.0% |
| Q4 2023 | $444 | +11.6% | 498,995 | +14.0% | 0.00% | 0.0% |
| Q3 2023 | $398 | -6.4% | 437,528 | -2.7% | 0.00% | 0.0% |
| Q2 2023 | $425 | +16.8% | 449,733 | +18.3% | 0.00% | – |
| Q1 2023 | $364 | -16.5% | 380,233 | -21.6% | 0.00% | -100.0% |
| Q4 2022 | $436 | -99.8% | 484,733 | +498.2% | 0.00% | – |
| Q3 2022 | $183,000 | -16.8% | 81,033 | -7.1% | 0.00% | – |
| Q2 2022 | $220,000 | +144.4% | 87,233 | +185.7% | 0.00% | – |
| Q1 2022 | $90,000 | -29.7% | 30,533 | +19.6% | 0.00% | – |
| Q4 2021 | $128,000 | – | 25,533 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,014,687 | $49,094,000 | 0.79% |
| Boxer Capital, LLC | 1,536,016 | $15,038,000 | 0.53% |
| Artal Group S.A. | 2,255,375 | $22,080,000 | 0.45% |
| Redmile Group, LLC | 2,088,089 | $20,442,000 | 0.30% |
| Affinity Asset Advisors, LLC | 80,000 | $783,000 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 292,194 | $2,861,000 | 0.19% |
| Orbimed Advisors | 1,584,845 | $15,516,000 | 0.16% |
| Baker Brothers Advisors | 2,591,366 | $25,369,000 | 0.11% |
| Perceptive Advisors | 1,510,750 | $14,790,000 | 0.10% |
| Monashee Investment Management LLC | 64,697 | $633,000 | 0.08% |